This page was translated automatically from Turkish. Read the original
This page is an AI-assisted Turkish summary of the study presented at the 26th World Congress of Psychiatry. The study belongs to the presenting authors; please refer to the original source when citing it.
EV1254
Sistemik immün inflamasyon indeksi ile değerlendirilen şizofrenide sistemik inflamatuvar yük: kontrollü bir olgu kontrol çalışması (Systemic inflammatory burden in schizophrenia assessed using the systemic immune-inflammation index: a controlled case-control study)
SYSTEMIC INFLAMMATORY BURDEN IN SCHIZOPHRENIA ASSESSED THROUGH THE SYSTEMIC IMMUNE INFLAMMATION INDEX: A CONTROLLED CASE CONTROL STUDY
Presenter: Andrei Gabriel Zanfir
Country: Romania
The systemic immune-inflammation index is higher in schizophrenia than in healthy controls, and this difference persists after adjustment for age and sex; however, its discriminatory ability is insufficient for diagnostic use.
The aim was to determine whether the systemic immune-inflammation index (SII) was elevated in adults with DSM-5-confirmed schizophrenia compared with psychiatrically healthy controls, and whether this association persisted after adjustment for age and sex. This controlled observational case-control study, conducted between March 2024 and January 2025, included 124 patients with schizophrenia taking atypical antipsychotics other than clozapine and 128 healthy controls screened for inflammatory and psychiatric conditions; exclusion criteria were autoimmune, chronic inflammatory, or hematological disease, recent infection, malignancy, substance use disorder, pregnancy or the postpartum period, and immunomodulatory treatment. Analyses included an independent-samples t-test, a chi-square test, ANCOVA, and ROC analysis. Mean SII was 610 ± 240 in the schizophrenia group and 520 ± 220 in controls (difference +90; t = 3.18; p = 0.002; Cohen's d = 0.39, a small-to-moderate effect size). Sex distribution differed between groups (χ² = 23.4; p<0.001), and the elevation persisted in the analysis adjusted for age and sex (F = 9.6; p = 0.002). ROC analysis showed only limited discriminatory ability, with an area under the curve (AUC) of 0.66 (95% confidence interval 0.59–0.73). The authors interpreted SII as reflecting susceptibility rather than diagnostic specificity.
View the original posterHow to cite this study
APA 7: Zanfir, A. G., et al. (2026, September 23-26). Systemic inflammatory burden in schizophrenia assessed through the systemic immune inflammation index: a controlled case control study [E-poster]. 26th WPA World Congress of Psychiatry (WCP 2026), Stockholm, Sweden. https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/520
Vancouver: Zanfir AG, et al. Systemic inflammatory burden in schizophrenia assessed through the systemic immune inflammation index: a controlled case control study [e-poster]. 26th WPA World Congress of Psychiatry (WCP 2026); 2026 Sep 23-26; Stockholm, Sweden. Available from: https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/520
Author names and title formatting were generated automatically from the congress system; please check them against the original poster before use.
On the same topic
- İlk atak psikoz ve esrar kullanım bozukluğu olan gençlerde yardım arama: Back to Reality video oyun serisinden çıkarımlar
- Kimyasal bağımlılığın eşlik ettiği tedaviye dirençli şizofreni hastalarında modern antipsikotiklerin kombine kullanımının klinik sonuçları
- Şizofrenide bilişsel gerileme: Sosyal işlevsellik üzerindeki etkisi ve bilişsel iyileştirme olanakları
- Ağır kişilerarası şiddet öyküsü olan, şizofrenisi olan ve olmayan bireylerde temel benlik bozukluklarının karşılaştırılması
- Yoğun çakra odaklı meditasyonla ilişkili bir ergende akut ve geçici psikotik bozukluk: olgu sunumu